Market Industry Reports (MIR) has published a new report titled “CRISPR Technology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.” According to the report, the global CRISPR technology market was valued at over US$ 550.0 Mn in 2017 and is expected to grow at a double digit CAGR during the forecasted period.
New York, NY -- (SBWIRE) -- 05/08/2019 -- CRISPR Technology Market is a comparatively new yet powerful technology that gives researchers the opportunity to adjust DNA sequences and modify gene function. It is used in genome editing or gene editing. CRISPR is the short form for "CRISPR-Case which is specialized stretches of DNA and has various applications. Case is an enzyme which can cut strands of DNA and also acts like a pair of molecular scissors.
CRISPR-Case Market has recently become prominent, is easy to use and even more efficient than the previously used best-genome editing tool. Researchers from the laboratories of Church and Feng Zhang of the Broad Institute of the Massachusetts Institute of Technology and Harvard were the first to publish their research that used CRISPR-Cas9 to edit human cells in an experimental setting. The food and agriculture industries have also seen the recent popularity of CRISPR technology that has been applied to devise robotic cultures and to vaccinate industrial cultures against viruses. The technology is also being used in crops to improve yield, its nutritional properties and drought tolerance.
GET your Sample PDF @ https://www.marketindustryreports.com/pdf/6
Key factors driving the growth of the market include the increasing funding from the private and government organizations and the high implementation of CRISPR technology. Currently, the technology is considered as a valuable tool for the biopharmaceutical and biotechnology companies to conduct highly efficient and cost effective genome editing procedures.
Increasing prevalence of genetic disorders, promoting the growth of market
The CRISPR technology is focused on development or growth of the gene therapeutics for the treatment of several genetic disorders including hemophilia, thalassemia, and sickle cell anemia, among others. The growing prevalence of hereditary disorders is promoting the growth of the market, for improved treatment and better quality of life for patients. According to Center for Disease Control and Prevention (CDC), in 2017, almost 1000 people in U.S. suffer from the most severe form of the thalassemia every year.
Browse key industry insights spread across 150 pages with market data tables & figures & charts from the report, CRISPR Technology Market by Product (CRISPR Enzymes, Kits), Service (Design & Vector Construction, Cell Line Engineering, Screening), Application (Biological & Biomedical, Agricultural, Industrial), End User (Pharmaceutical & Biotechnology Companies, Academics Institutes & Research Centers, CROs) - Global Analysis & Forecast 2019-2030 in detail along with the table of contents: https://www.marketindustryreports.com/6/crispr-technology-market
Key Points From Table of Contents
COMPETITIVE LANDSCAPE
1. Market Share Analysis (2018)
2. Key Strategies Assessment
2.1. New Product Launches
2.2. Merger & Acquisitions
2.3. Agreements, Collaborations, & Partnerships
2.4. Expansions
2.5. Other Strategies
COMPANY PROFILES
(Business Overview, Products/Services Offered, Financial Performance, R&D Intensity, Marketing & Sales Intensity, Recent Developments, Analyst Corner)*
3.1 Merck KGaA
3.2 Thermo Fisher Scientific
3.3 Agilent Technologies
3.4 Integrated DNA Technologies (IDT)
3.5 GenScript
3.6 GeneCopoeia, Inc.
3.7 New England Biolabs
3.8 Origene Technologies, Inc.
3.9 Transposagen Biopharmaceuticals, Inc
3.10 Applied StemCell. Inc.
(*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)
(*Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain)
Repeated off-target and safety studies to restrain the market growth
Reducing the length of the director sequence from 20 to 18 nucleotides can increase specificity up to 5,000 times without affecting cutting efficiency. However, every new CRISPR-based therapy requires a new sgRNA, safety and off-target studies will need to be performed each time which is expected to restrain growth of the market.
#This Reports Includes Segmental analysis, Regional analysis, Research Methodology, Competitive Landscape, Learn how to build the strategy and business case to implement Order Here@ https://www.marketindustryreports.com/checkout/6
About Market Industry Reports:
Market Industry Reports is a global leader in market measurement & advisory services, Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
We continue to pioneer state-of-the-art approach in research & analysis that makes complex world simpler to stay ahead of the curve. By nurturing the perception of genius and optimized market intelligence we bring proficient contingency to our clients in the evolving world of technologies, megatrends and industry convergence. We empower and inspire Vanguards to fuel and shape their business to build and grow world-class consumer products.
Contact Us-
502, Sai Radhe, Kennedy Road,
Behind Hotel Sheraton Grand,
Near Pune Station, Pune 411 001
Email: sales@marketindustryreports.com
Phone: + 91 967-353-5933
Website: https://www.marketindustryreports.com/
Follow Us- LinkedIn | Twitter | Google+ | Face book